ISSN2456-3315
Impact Factor10.57
UGC CAREApproved
Low Cost₹599 / $45
CrossRefDOI
ESTD2016
Peer ReviewTransparent
AccessOpen
Submission: Always Open
Paper Title
Precision Medicines and Its Targeted activity in Multiple types of Breast Cancer
Authors
Ms. Pooja S Murkute , Mr. Aditya A More , Mr. Nakul P Kathar , Dr. Gajanan.S. Sanap , Mr. Rahul R Pawar
Keywords
Breast Cancer, Precision Medicine, Triple-Negative Breast Cancer, BRC A1, BRC A2, HER2 targeted medicine, Pertuzumab, Trastuzumab-DM1, Neratinib, Trastuzumab
Abstract
Precision medicine is a medicine advance to the genotypic and phenotypic feature of an individual. It has host of destination including gene and their transcript protein and metabolite. Precision medicine and targeted therapies have long record in treatment of breast cancer. Breast cancer is the most common cancer among women is a highly complex, heterogeneous and multifactorial disease. It is cancer that start in breast when cells begin to grow out of control. Breast cancer have demonstrated prediction and support advantage thanks to the discovery of targeted therapies the advent of these new approaches marked the rise of precision medicine, which lead to improve the diagnosis, prediction and treatment of cancer. This article describes the important of precision medicine and targeted therapies in breast cancer
Full Paper, Downloads & Preview
How To Cite
Choose the style your journal or department asks for, then copy it. Every version below is generated from this paper's own record.
IJRTI — journal style
"Precision Medicines and Its Targeted activity in Multiple types of Breast Cancer", IJRTI - International Journal for Research Trends and Innovation (www.ijrti.org), ISSN:2456-3315, Vol.7, Issue 2, page no.57 - 66, February-2022, Available :https://ijrti.org/papers/IJRTI2202009.pdf
APA — 7th edition
Murkute, P. S., More, A. A., Kathar, N. P., Sanap, G. S., & Pawar, R. R. (2022). Precision Medicines and Its Targeted activity in Multiple types of Breast Cancer. International Journal for Research Trends and Innovation, 7(2), 57 - 66. https://ijrti.org/viewpaperforall.php?paper=IJRTI2202009
MLA — 9th edition
Murkute, Pooja S, et al. "Precision Medicines and Its Targeted activity in Multiple types of Breast Cancer." International Journal for Research Trends and Innovation, vol. 7, no. 2, 2022, pp. 57 - 66, https://ijrti.org/viewpaperforall.php?paper=IJRTI2202009.
Chicago — 17th, bibliography
Murkute, Pooja S, et al. "Precision Medicines and Its Targeted activity in Multiple types of Breast Cancer." International Journal for Research Trends and Innovation 7, no. 2 (2022): 57 - 66. https://ijrti.org/viewpaperforall.php?paper=IJRTI2202009.
Harvard — author–date
Murkute, P.S. et al. (2022) 'Precision Medicines and Its Targeted activity in Multiple types of Breast Cancer', International Journal for Research Trends and Innovation, 7(2), pp. 57 - 66. Available at: https://ijrti.org/viewpaperforall.php?paper=IJRTI2202009
IEEE — numbered reference
P. S. Murkute, A. A. More, N. P. Kathar, G. S. Sanap and R. R. Pawar, "Precision Medicines and Its Targeted activity in Multiple types of Breast Cancer," IJRTI, vol. 7, no. 2, pp. 57 - 66, Feb. 2022.
Vancouver — biomedical
Murkute PS, More AA, Kathar NP, Sanap GS, Pawar RR. Precision Medicines and Its Targeted activity in Multiple types of Breast Cancer. IJRTI. 2022 Feb;7(2):57 - 66.
AMA — 11th edition
Murkute PS, More AA, Kathar NP, Sanap GS, Pawar RR. Precision Medicines and Its Targeted activity in Multiple types of Breast Cancer. IJRTI. 2022;7(2):57 - 66. Accessed at https://ijrti.org/viewpaperforall.php?paper=IJRTI2202009
BibTeX — Zotero, Mendeley, LaTeX
@article{IJRTI2202009,
author = {Pooja S Murkute and Aditya A More and Nakul P Kathar and Gajanan.S. Sanap and Rahul R Pawar},
title = {Precision Medicines and Its Targeted activity in Multiple types of Breast Cancer},
journal = {International Journal for Research Trends and Innovation},
volume = {7},
number = {2},
pages = {57 - 66},
year = {2022},
month = {February},
issn = {2456-3315},
url = {https://ijrti.org/viewpaperforall.php?paper=IJRTI2202009}
}
RIS — EndNote, RefWorks
TY - JOUR
AU - Murkute, Pooja S
AU - More, Aditya A
AU - Kathar, Nakul P
AU - Sanap, Gajanan.S.
AU - Pawar, Rahul R
TI - Precision Medicines and Its Targeted activity in Multiple types of Breast Cancer
T2 - International Journal for Research Trends and Innovation
JA - IJRTI
VL - 7
IS - 2
PY - 2022
SN - 2456-3315
UR - https://ijrti.org/viewpaperforall.php?paper=IJRTI2202009
SP - 57
EP - 66
ER -
Issue
Volume 7 Issue 2,
February-2022
Pages : 57 - 66
Other Publication Details
Paper Reg. ID
IJRTI_181703
Published Paper ID
IJRTI2202009
Downloads
205,730
Research Area
Pharmacy
Country
AURANGABAD, Maharashtra, India
Published
February 2022
Published Paper PDF
https://ijrti.org/papers/IJRTI2202009.pdf
Published Paper URL
https://ijrti.org/viewpaperforall.php?paper=IJRTI2202009
About Publisher
International Journal for Research Trends and Innovation
Published by IJRTI (JW Publication)
2456-3315
ISSN
10.57
Impact Factor
2016
ESTD Year
Open
Access
Impact Factor 10.57 calculated by Google Scholar and Semantic Scholar.
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 10.57 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
UGC CARE Approved Journal — Transparent Peer-reviewed journal aligned with UGC’s 2025 suggestive parameters, with CrossRef DOI registration and Scopus Standard metadata on every published paper.
Licence
© 2022 — Authors hold the copyright of this article.
This work is licensed under a
Creative Commons Attribution 4.0 International License
and The Open Definition.
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0),
which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Disclaimer:
The content, data and findings in this article are based on the authors’ research and have been
peer-reviewed for academic purposes only. Readers are advised to verify all information before practical
or commercial use. The journal and its editorial board are not liable for any errors, losses or
consequences arising from its use.
Declarations
Funding
No external funding was received for this study.
Conflict of Interest
The authors declare that they have no conflict of interest.
Acknowledgements
The authors would like to thank the reviewers and the editorial board of International Journal for Research Trends and Innovation for their careful reading and constructive comments, and all colleagues who supported the preparation of this manuscript.
